A detailed history of Tower Research Capital LLC (Trc) transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 6,924 shares of ROIV stock, worth $87,865. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,924
Previous 10,378 33.28%
Holding current value
$87,865
Previous $109,000 27.52%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.17 - $12.5 $35,127 - $43,175
-3,454 Reduced 33.28%
6,924 $79,000
Q2 2024

Aug 13, 2024

SELL
$10.36 - $11.74 $2.62 Million - $2.97 Million
-252,670 Reduced 96.05%
10,378 $109,000
Q1 2024

May 15, 2024

BUY
$9.87 - $11.8 $2.5 Million - $2.99 Million
253,377 Added 2619.97%
263,048 $2.77 Million
Q4 2023

Feb 13, 2024

SELL
$8.38 - $11.58 $22,290 - $30,802
-2,660 Reduced 21.57%
9,671 $108,000
Q3 2023

Nov 14, 2023

BUY
$9.76 - $13.19 $9,389 - $12,688
962 Added 8.46%
12,331 $144,000
Q2 2023

Aug 14, 2023

SELL
$7.09 - $10.08 $23,439 - $33,324
-3,306 Reduced 22.53%
11,369 $114,000
Q1 2023

May 09, 2023

BUY
$6.92 - $9.98 $85,482 - $123,282
12,353 Added 532.0%
14,675 $108,000
Q4 2022

Feb 10, 2023

SELL
$3.36 - $7.99 $10,261 - $24,401
-3,054 Reduced 56.81%
2,322 $18,000
Q3 2022

Nov 10, 2022

SELL
$0.51 - $4.84 $9,242 - $87,715
-18,123 Reduced 77.12%
5,376 $17,000
Q2 2022

Aug 15, 2022

BUY
$2.81 - $4.84 $49,840 - $85,847
17,737 Added 307.83%
23,499 $95,000
Q1 2022

May 12, 2022

BUY
$4.74 - $9.91 $24,240 - $50,679
5,114 Added 789.2%
5,762 $28,000
Q4 2021

Feb 14, 2022

BUY
$5.86 - $13.52 $3,797 - $8,760
648 New
648 $7,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.94B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.